Collaboration to develop rapid CJD (Creutzfeld Jakob disease) test:
This article was originally published in Clinica
Executive Summary
Prionics, the Swiss firm that found an antibody specific to BSE and a form of Creutzfeld Jakob disease in humans (see Clinica No 782, p 21), is to team up with a US genomics firm to develop a blood test for the rogue prion protein that causes the diseases. Paradigm Genetics, of Research Triangle park, North Carolina, will work with Zurich-based Prionics on a rapid, high throughput test which could be used for human diagnostics within several years.